These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38310460)

  • 1. Effect of Neoadjuvant Immunotherapy Combined with Chemotherapy on Pulmonary Function and Postoperative Pulmonary Complications in Esophageal Cancer: A Retrospective Study.
    Gao Y; Zhang H; Qiu Y; Bian X; Wang X; Li Y
    Curr Cancer Drug Targets; 2024; 24(10):1061-1070. PubMed ID: 38310460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of neoadjuvant immunotherapy on pulmonary function and perioperative outcomes in patients with resectable non-small cell lung cancer].
    Zhu Y; Li JQ; Chang Q; Qiang HP; Lu JH; Feng H; Shen YC; Qian JL; Chu TQ
    Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):393-398. PubMed ID: 35144337
    [No Abstract]   [Full Text] [Related]  

  • 3. Additional neoadjuvant immunotherapy does not increase the risk of anastomotic leakage after esophagectomy for esophageal squamous cell carcinoma: a multicenter retrospective cohort study.
    Hong Z; Xu J; Chen Z; Xu H; Huang Z; Weng K; Cai J; Ke S; Chen S; Xie J; Duan H; Kang M
    Int J Surg; 2023 Aug; 109(8):2168-2178. PubMed ID: 37318861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer.
    Populaire P; Defraene G; Nafteux P; Depypere L; Moons J; Isebaert S; Haustermans K
    Acta Oncol; 2023 Nov; 62(11):1488-1495. PubMed ID: 37643135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma.
    Lv H; Zhang F; Huang C; Xu S; Li J; Sun B; Gai C; Liu Z; Wang M; Li Z; Tian Z
    J Cancer Res Clin Oncol; 2024 May; 150(5):260. PubMed ID: 38760614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer.
    Goense L; Meziani J; Bülbül M; Braithwaite SA; van Hillegersberg R; Ruurda JP
    Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30239639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
    Xu L; Wei XF; Li CJ; Yang ZY; Yu YK; Li HM; Xie HN; Yang YF; Jing WW; Wang Z; Kang XZ; Zhang RX; Qin JJ; Xue LY; Bi N; Chen XK; Li Y
    Front Immunol; 2022; 13():1052542. PubMed ID: 36466925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching.
    Hong ZN; Zhang Z; Chen Z; Weng K; Peng K; Lin J; Kang M
    Esophagus; 2022 Apr; 19(2):224-232. PubMed ID: 34988773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
    Elliott JA; O'Byrne L; Foley G; Murphy CF; Doyle SL; King S; Guinan EM; Ravi N; Reynolds JV
    Br J Surg; 2019 Sep; 106(10):1341-1351. PubMed ID: 31282584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Feasibility of Esophagectomy Following Combined Immunotherapy and Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Analysis.
    Hong ZN; Gao L; Weng K; Huang Z; Han W; Kang M
    Front Immunol; 2022; 13():836338. PubMed ID: 35300335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative DLco and FEV
    Kim T; Jeon YJ; Lee H; Kim TH; Park SY; Kang D; Hong YS; Lee G; Lee J; Shin S; Cho JH; Choi YS; Kim J; Cho J; Zo JI; Shim YM; Kim HK; Park HY
    Sci Rep; 2024 Mar; 14(1):6117. PubMed ID: 38480929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma.
    Cheng D; Zhao W; Chen R; Li D; Tang S; Fang C; Ji M
    World J Surg Oncol; 2023 Feb; 21(1):33. PubMed ID: 36737768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Body Composition on Clinical Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Plus Chemotherapy.
    Zhao Y; Xia M; Dang Y; Li Y; Zhao X; Kang N; Zuo J; Zhang R
    Ann Ital Chir; 2024; 95(3):284-293. PubMed ID: 38918965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of Short-term Efficacy of Neoadjuvant Immunotherapy Combined with Chemotherapy and Surgery Alone for Locally Advanced Resectable 
Non-small Cell Lung Cancer].
    Li H; Liu Q; Li B; Chen Y; Lin J; Meng Y; Feng H; Zheng Z; Hui Y
    Zhongguo Fei Ai Za Zhi; 2024 Jun; 27(6):421-430. PubMed ID: 39026493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study.
    Zhang H; Zhang Z; Yang L; Wu B; Chen Y; He H; Li C; Lin W; Lin J
    J Thorac Dis; 2023 Mar; 15(3):1279-1288. PubMed ID: 37065590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery.
    Cho WK; Oh D; Kim HK; Ahn YC; Noh JM; Shim YM; Zo JI; Choi YS; Sun JM; Lee SH; Ahn MJ; Park K; Nam H
    Radiother Oncol; 2019 Apr; 133():87-92. PubMed ID: 30935586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta-analysis.
    Zhou D; Chen D; Song P; Hu Z; Xu S; Zhu R; Chen Y
    J Evid Based Med; 2024 Sep; 17(3):559-574. PubMed ID: 39161209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of minimally invasive gastrectomy for older patients with gastric cancer after neoadjuvant chemotherapy and immunotherapy: a propensity score-matched analysis.
    Cui H; Yuan Z; Liang W; Cao B; Chen L; Cui J; Wei B
    BMC Geriatr; 2024 Jul; 24(1):606. PubMed ID: 39009976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A propensity score-matched analysis of neoadjuvant chemoimmunotherapy versus surgery alone for locally advanced esophageal squamous cell carcinoma.
    Wang K; Liang Y; Huang J; Xie X; Wu D; Chen B; Wang K; Shen Z; Li Y; Wang W; Hu X; Wang M
    J Surg Oncol; 2023 Aug; 128(2):207-217. PubMed ID: 37036218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.